サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/12/02 | 2,156.5 | 2,159.5 | 2,137.5 | 2,154 | -20.5 | -0.9% | 673,300 |
2024/11/29 | 2,159 | 2,176 | 2,108 | 2,174.5 | -2 | -0.1% | 944,800 |
2024/11/28 | 2,064 | 2,197 | 2,055 | 2,176.5 | +124 | +6% | 1,399,800 |
2024/11/27 | 2,016.5 | 2,054 | 2,010 | 2,052.5 | +36 | +1.8% | 687,600 |
2024/11/26 | 1,987.5 | 2,016.5 | 1,966 | 2,016.5 | +29 | +1.5% | 707,700 |
2024/11/25 | 1,994 | 1,999 | 1,965.5 | 1,987.5 | +15.5 | +0.8% | 708,400 |
2024/11/22 | 1,950 | 1,984.5 | 1,938.5 | 1,972 | -2.5 | -0.1% | 714,000 |
2024/11/21 | 1,940 | 1,995.5 | 1,933.5 | 1,974.5 | +27.5 | +1.4% | 816,000 |
2024/11/20 | 1,920.5 | 1,947 | 1,917.5 | 1,947 | +29 | +1.5% | 670,700 |
2024/11/19 | 1,921.5 | 1,929 | 1,909 | 1,918 | +16 | +0.8% | 617,600 |
2024/11/18 | 1,899 | 1,902 | 1,868.5 | 1,902 | -14.5 | -0.8% | 750,100 |
2024/11/15 | 1,917.5 | 1,939 | 1,903.5 | 1,916.5 | -1 | -0.1% | 763,900 |
2024/11/14 | 1,925 | 1,959.5 | 1,916.5 | 1,917.5 | -7.5 | -0.4% | 848,400 |
2024/11/13 | 1,900 | 1,937 | 1,900 | 1,925 | +33 | +1.7% | 1,160,200 |
2024/11/12 | 1,900 | 1,969 | 1,890.5 | 1,892 | -136.5 | -6.7% | 2,369,400 |
2024/11/11 | 2,013 | 2,045 | 1,991 | 2,028.5 | +57 | +2.9% | 1,532,600 |
2024/11/08 | 1,989 | 2,003.5 | 1,884 | 1,971.5 | -17.5 | -0.9% | 1,417,600 |
2024/11/07 | 1,990.5 | 2,014.5 | 1,978.5 | 1,989 | -7.5 | -0.4% | 1,021,200 |
2024/11/06 | 1,990 | 2,024 | 1,990 | 1,996.5 | -3.5 | -0.2% | 600,100 |
2024/11/05 | 1,981 | 2,000 | 1,962.5 | 2,000 | +11 | +0.6% | 657,600 |
2024/11/01 | 2,010 | 2,029.5 | 1,983 | 1,989 | -60 | -2.9% | 578,800 |
2024/10/31 | 2,043.5 | 2,058.5 | 2,031 | 2,049 | +26.5 | +1.3% | 562,700 |
2024/10/30 | 2,016.5 | 2,042 | 2,000 | 2,022.5 | -3 | -0.1% | 3,221,800 |
2024/10/29 | 2,012 | 2,025.5 | 1,998 | 2,025.5 | +3.5 | +0.2% | 653,800 |
2024/10/28 | 1,990.5 | 2,028.5 | 1,985.5 | 2,022 | +37.5 | +1.9% | 623,800 |
2024/10/25 | 2,016.5 | 2,025.5 | 1,965 | 1,984.5 | -28.5 | -1.4% | 626,100 |
2024/10/24 | 1,982 | 2,028.5 | 1,980 | 2,013 | +20 | +1% | 503,400 |
2024/10/23 | 2,009 | 2,017.5 | 1,975.5 | 1,993 | -22 | -1.1% | 674,600 |
2024/10/22 | 2,046.5 | 2,046.5 | 2,006 | 2,015 | -42 | -2% | 776,800 |
2024/10/21 | 2,051 | 2,098.5 | 2,047 | 2,057 | +15 | +0.7% | 601,600 |
2024/10/18 | 2,047 | 2,059 | 2,028 | 2,042 | -14 | -0.7% | 1,070,500 |
2024/10/17 | 2,090 | 2,090 | 2,050.5 | 2,056 | -37 | -1.8% | 527,900 |
2024/10/16 | 2,113.5 | 2,136.5 | 2,092.5 | 2,093 | -25 | -1.2% | 566,100 |
2024/10/15 | 2,115 | 2,129 | 2,105 | 2,118 | +3 | +0.1% | 713,000 |
2024/10/11 | 2,130 | 2,130 | 2,098 | 2,115 | -45 | -2.1% | 857,300 |
2024/10/10 | 2,139 | 2,160 | 2,114 | 2,160 | +10 | +0.5% | 682,700 |
2024/10/09 | 2,122 | 2,150 | 2,122 | 2,150 | +28.5 | +1.3% | 575,700 |
2024/10/08 | 2,109 | 2,124 | 2,078 | 2,121.5 | -25 | -1.2% | 717,200 |
2024/10/07 | 2,122.5 | 2,161 | 2,104.5 | 2,146.5 | +13.5 | +0.6% | 664,600 |
2024/10/04 | 2,083.5 | 2,135 | 2,082 | 2,133 | +49.5 | +2.4% | 782,000 |
2024/10/03 | 2,130 | 2,139 | 2,072.5 | 2,083.5 | -17.5 | -0.8% | 660,300 |
2024/10/02 | 2,050 | 2,105 | 2,037.5 | 2,101 | +31 | +1.5% | 601,300 |
2024/10/01 | 2,046 | 2,072 | 2,037 | 2,070 | +32.5 | +1.6% | 490,800 |
2024/09/30 | 2,028.5 | 2,069.5 | 2,020 | 2,037.5 | -41 | -2% | 472,000 |
2024/09/27 | 2,120 | 2,148.5 | 2,076.5 | 2,078.5 | -4,341.5 | -67.6% | 512,000 |
2024/09/26 | 6,370 | 6,420 | 6,309 | 6,420 | +48 | +0.8% | 261,100 |
2024/09/25 | 6,377 | 6,381 | 6,298 | 6,372 | +24 | +0.4% | 139,500 |
2024/09/24 | 6,249 | 6,385 | 6,205 | 6,348 | +184 | +3% | 192,800 |
2024/09/20 | 6,236 | 6,236 | 6,144 | 6,164 | -37 | -0.6% | 290,600 |
2024/09/19 | 6,090 | 6,265 | 6,080 | 6,201 | +121 | +2% | 229,500 |
101~
150
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム